Synthesis and characterization of new thebaine derivatives as potential opioid agonists and antagonists: 2-[ N -(1 H -Tetrazol-5-yl)-6,14-endo-etheno-6, 7,8,14-tetrahydrothebaine-7α-yl]-5-phenyl-1,3,4-oxadiazoles

Journal of Heterocyclic Chemistry

Volumn 50, Issue SUPPL.1, 2013, Pages

  Yildirir, Yilmaz ^a   Pamir, Özgür ^a   Yavuz, Serkan ^a   Dişli, Ali ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

2 [N (1H TETRAZOL 5 YL) 6,14 ENDO ETHENO 6,7,8,14 TETRAHYDROTHEBAINE 7 ALPHA YL] 5 PHENYL 1,3,4 OXADIAZOLE; 2 [N (TETRAZOL 1H 5 YL) 6,14 ENDO ETHENO 6,7,8,14 TETRAHYDROTHEBAINE 7 YL] 5(4 METHOXYPHENYL) 1,3,4 OXADIAZOLE; 2 [N (TETRAZOL 1H 5 YL) 6,14 ENDO ETHENO 6,7,8,14 TETRAHYDROTHEBAINE 7ALPHA YL] 5 (4' BROMOPHENYL) 1,3,4 OXADIAZOLE; 2 [N (TETRAZOL 1H 5 YL) 6,14 ENDO ETHENO 6,7,8,14 TETRAHYDROTHEBAINE 7ALPHA YL] 5 (4' FLUOROPHENYL) 1,3,4 OXADIAZOLE; 2 [N (TETRAZOL 1H 5 YL) 6,14 ENDO ETHENO 6,7,8,14TETRAHYDROTHEBAINE 7ALPHA YL] 5 (4' CHLOROPHENYL) 1,3,4 OXADIAZOLE; NITROGEN; OPIATE AGONIST; OPIATE ANTAGONIST; TETRAZOLE DERIVATIVE; THEBAINE; UNCLASSIFIED DRUG;

ARTICLE; ATOM; DRUG STRUCTURE; DRUG SYNTHESIS; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR MULTIPLE QUANTUM COHERENCE; INFRARED SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; SUBSTITUTION REACTION;

EID: 84876932591     PISSN: 0022152X     EISSN: 19435193     Source Type: Journal    
DOI: 10.1002/jhet.1074     Document Type: Article

References (22)

1. Dhawan, B. N.,;, Cesselin, F.,;, Raghubir, T.,;, Reisine, T.,;, Bradley, P. B.,;, Portoghesse, P. S.,;, Hamon, M., Pharmacol Rev 1996, 48, 567.
2. Sporer, K. A., Ann Int Med 1999, 130, 584.
3. Nutt, D. J., Lancet 1996, 347, 31.
4. Spanagel, R.,;, Herz, A.,;, Shippenberg, T. S., J Neurochem 1990, 55, 1734.
5. Kalinin, V. N.,;, Shishkov, I. V.,;, Moiseev, S. K.,;, Shults, E. E.,;, Tolstikov, G. A.,;, Sosnina, N. I.,;, Petrovskii, P. V.,;, Lyssenko, K. A., Helv Chim Acta 2006, 89, 861.
6. Yavuz, S.,;, Yildirir, Y., Helv Chim Acta 2010, 93, 2406.
7. Lewis, J. W.,;, Husbands, S. M., J Med Chem 2004, 43, 139.
8. Lewis, J. W.,;, Husbands, S. M., Curr Pharm Design 2004, 10, 717.
9. Maat, L.,;, Woudenberg, R. H.,;, Meuzelaar, G. J.,;, Linders, J. T. M., Bioorg Med Chem 1999, 7, 529.
10. Bentley, K. W.,;, Hardy, D. G., J Am Chem Soc 1967, 89, 3267.
11. Takemori, A. E.,;, Hayashi, G.,;, Smits, S. E., Eur J Pharmacol 1972, 20, 85.
12. Zhang, A.,;, Li, F.,;, Ding, C.,;, Yao, Q.,;, Bidlack, J. M.,;, Hilbert, J. E.,;, Knapp, B. I.,;, Neumeyer, J. L., J Med Chem 2007, 50, 2747.
13. Liu, C. H.,;, Zhong, B.,;, Liu, C.,;, Wu, B.,;, Gong, Z., Acta Chim Slov 2005, 52, 80.
14. Dolman, S. J.,;, Gosselin, F.,;, O′Shea, P. D.,;, Davies, I. W., J Org Chem 2006, 71, 9584.
15. Tully, W. R.,;, Gardner, C. R.,;, Gillespie, R. J.,;, Westwood, R., J Med Chem 1991, 34, 2060.
16. Holla, B. S.,;, Gonsalves, R.,;, Shenoy, S., Eur J Med Chem 2000, 35, 267.
17. Lenz, G. R.,;, Evans, S. M.,;, Walters, D. E.,;, Hopfinger, A. J., Opiates; Academic Press: Orlando, 1986.
18. Nogrady, T., Medicinal Chemistry-A Biochemical Approach; Oxford University Press: Oxford, UK, 1988.
19. Jin, T.,;, Kamijo, S.,;, Yamamoto, Y., Tetrahedron Lett 2004, 45, 9435.
20. Odabasoglu, M.,;, Yavuz, S.,;, Pamir, Ö.,;, Yildirir, Y.,;, Büyükgüngör, O., Acta Crystalogr 2009, 65, o864.
21. Bentley, K. W.,;, Hardy, D. G.,;, Smith, A. C. B., J Chem Soc C 1969, 2235.
22. Bentley, K. W.,;, Burton, M.,;, Uff, B. C., J Med Chem 1984, 27, 1276.